Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in Adolescents with Axillary Hyperhidrosis
NCT00168415Phase 4Completed
- Sponsor
- Allergan
- Start
- Aug 2005
- Primary completion
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial of onabotulinumtoxinA in axillary hyperhidrosis, sponsored by Allergan. Primary endpoint: Hyperhidrosis Disease Severity Scale. Started Aug 2005; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
axillary hyperhidrosis
Beyond the preview
Go deeper on NCT00168415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168415.